---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-086761"
form_type: "8-K"
ticker: "ASTH"
cik: "0001083446"
company_name: "Astrana Health, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:35:28.054674+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Astrana Health Q2 revenue up 40% to $486.3M, EPS $0.40; acquires CHS from Centene

## Summary
- Q2 revenue $486.3M (+40% YoY), net income $19.2M (+46%), diluted EPS $0.40 (+43%), adjusted EBITDA $47.9M (+34%).
- Six-month revenue $890.6M (+30%), net income $34.0M (+29%), diluted EPS $0.71, adjusted EBITDA $90.2M (+38%).
- Entered Arizona via partnership with 45+ PCP group; Hawaii via Elation Health partnership covering ~20K Medicare patients.
- Definitive agreement to acquire Collaborative Health Systems from Centene (~2,500 PCPs, 100K+ beneficiaries) expected Q4 2024.
- Updated FY2024 revenue guidance $1.75B-$1.85B; reiterated adjusted EBITDA $165M-$185M.

## SEC filing metadata
- accession: 0001104659-24-086761
- form_type: 8-K
- ticker: ASTH
- cik: 0001083446
- company_name: Astrana Health, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1083446/000110465924086761/0001104659-24-086761-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1083446/000110465924086761/tm2420865d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-086761
- JSON: https://secwatch.observer/filing/0001104659-24-086761.json
- Plain text: https://secwatch.observer/filing/0001104659-24-086761.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.